EYOMNI Trademark

Trademark Overview


On Monday, November 13, 2017, a trademark application was filed for EYOMNI with the United States Patent and Trademark Office. The USPTO has given the EYOMNI trademark a serial number of 79227957. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, July 18, 2025. This trademark is owned by Santen Pharmaceutical Co., Ltd.. The EYOMNI trademark is filed in the Pharmaceutical Products category with the following description:

Collyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions; pharmaceutical preparations for treatment of pinguecula; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules for medicines, namely, capsules sold empty ...
eyomni

General Information


Serial Number79227957
Word MarkEYOMNI
Filing DateMonday, November 13, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, July 18, 2025
Registration Number5640039
Registration DateTuesday, January 1, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 16, 2018

Trademark Statements


Goods and ServicesCollyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions; pharmaceutical preparations for treatment of pinguecula; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules for medicines, namely, capsules sold empty for pharmaceuticals and drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton, namely, cotton for medical purposes, cotton sticks for medical purposes and antiseptic cotton; adhesive plasters, namely, adhesive plasters for medical purposes, sticking plasters for medical purposes and medical and surgical plasters; bandages for dressings; liquid bandages, namely, antiseptic liquid bandages, liquid bandage sprays and liquid bandages for skin wounds; breast-nursing pads; cotton sticks for medical purposes; incontinence diapers; diapers; diaper covers, namely, inserts specially adapted for cloth infant diapers made of microfiber and infant diaper covers of textile; dietary supplements for humans; nutritional supplements; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies, namely, infant formula and meal replacement beverages for babies adapted for medical use; food for babies; dietary supplements for animals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateSaturday, July 19, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanten Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameSanten Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameSanten Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Saturday, March 10, 2018APPLICATION FILING RECEIPT MAILED
Wednesday, March 14, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 21, 2018REFUSAL PROCESSED BY MPU
Thursday, March 1, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, March 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 6, 2018ASSIGNED TO EXAMINER
Tuesday, March 13, 2018NON-FINAL ACTION WRITTEN
Friday, April 6, 2018REFUSAL PROCESSED BY IB
Thursday, August 30, 2018ASSIGNED TO LIE
Wednesday, September 26, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 26, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 21, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, August 15, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 7, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 10, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 26, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, October 12, 2018NOTIFICATION PROCESSED BY IB
Tuesday, October 16, 2018PUBLISHED FOR OPPOSITION
Tuesday, October 16, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 1, 2019REGISTERED-PRINCIPAL REGISTER
Monday, April 1, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, April 22, 2019FINAL DISPOSITION PROCESSED
Friday, May 10, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, May 1, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, April 22, 2019FINAL DISPOSITION NOTICE SENT TO IB
Monday, January 1, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 18, 2025CANCELLED SECTION 71